University of California at Los Angeles TORI Central Monitring Site
Los Angeles, California 90095
We've found
1 trials
at this facility
Oncology Clinical Trial
Updated: 2/24/2014
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Status: Enrolling,
Phase
II
Updated: 2/24/2014
Click here to add this to my saved trials